| Primary |
| Diabetes Mellitus |
51.1% |
| Type 2 Diabetes Mellitus |
12.9% |
| Hypertension |
12.6% |
| Cerebral Infarction |
2.5% |
| Meningitis Viral |
2.2% |
| Type 1 Diabetes Mellitus |
2.2% |
| Bipolar I Disorder |
1.8% |
| Constipation |
1.4% |
| Diabetes Mellitus Management |
1.4% |
| Gastritis |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Hyperlipidaemia |
1.4% |
| Drug Eruption |
1.1% |
| Dyslipidaemia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Polymyalgia Rheumatica |
1.1% |
| Prophylaxis |
1.1% |
| Back Pain |
0.7% |
| Cardiac Failure Congestive |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
|
| Rhabdomyolysis |
17.4% |
| Lactic Acidosis |
13.0% |
| Vomiting |
8.7% |
| Renal Impairment |
7.2% |
| Blood Creatine Phosphokinase Increased |
5.8% |
| Hypoglycaemia |
5.8% |
| Myalgia |
5.8% |
| Decreased Appetite |
4.3% |
| Rash |
4.3% |
| Drug-induced Liver Injury |
2.9% |
| Gastric Ulcer |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Liver Disorder |
2.9% |
| Nausea |
2.9% |
| Renal Failure |
2.9% |
| Renal Failure Acute |
2.9% |
| Thrombocytopenia |
2.9% |
| Accidental Exposure To Product By Child |
1.4% |
| Agranulocytosis |
1.4% |
| Anaemia |
1.4% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
20.7% |
| Diabetes Mellitus |
19.3% |
| Rheumatoid Arthritis |
14.5% |
| Product Used For Unknown Indication |
13.1% |
| Hypertension |
11.7% |
| Cystitis |
4.1% |
| Dyslipidaemia |
2.8% |
| Angina Pectoris |
1.4% |
| Diabetic Neuropathy |
1.4% |
| Eczema |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Hyperlipidaemia |
1.4% |
| Musculoskeletal Pain |
1.4% |
| Osteoporosis |
1.4% |
| Benign Prostatic Hyperplasia |
0.7% |
| Cervicobrachial Syndrome |
0.7% |
| Gastritis |
0.7% |
| Gastritis Prophylaxis |
0.7% |
| Herpes Zoster |
0.7% |
| Ischaemic Stroke |
0.7% |
|
| Intraductal Proliferative Breast Lesion |
12.5% |
| Off Label Use |
12.5% |
| Drug-induced Liver Injury |
8.3% |
| Surgery |
8.3% |
| Bile Duct Cancer |
4.2% |
| Erythema Nodosum |
4.2% |
| Jaundice |
4.2% |
| Malignant Peritoneal Neoplasm |
4.2% |
| Myocardial Infarction |
4.2% |
| Rash |
4.2% |
| Renal Failure Acute |
4.2% |
| Rhabdomyolysis |
4.2% |
| Road Traffic Accident |
4.2% |
| Tricuspid Valve Incompetence |
4.2% |
| Vitreous Haemorrhage |
4.2% |
| Vomiting |
4.2% |
| Weight Increased |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
|
| Concomitant |
| Diabetes Mellitus |
24.5% |
| Type 2 Diabetes Mellitus |
15.6% |
| Chronic Hepatitis C |
13.7% |
| Hypertension |
9.1% |
| Product Used For Unknown Indication |
8.8% |
| Prophylaxis |
5.2% |
| Hypercholesterolaemia |
3.0% |
| Hiv Infection |
2.8% |
| Hyperlipidaemia |
2.5% |
| Constipation |
2.0% |
| Insomnia |
1.8% |
| Rheumatoid Arthritis |
1.6% |
| Hepatitis C |
1.5% |
| Pain |
1.4% |
| Angina Pectoris |
1.3% |
| Neuropathy Peripheral |
1.2% |
| Psoriasis |
1.2% |
| Myocardial Infarction |
1.0% |
| Cardiac Failure Chronic |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Vomiting |
12.9% |
| Renal Impairment |
8.9% |
| Pancreatic Carcinoma |
6.9% |
| Rash |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Interstitial Lung Disease |
5.9% |
| White Blood Cell Count Increased |
5.9% |
| Erythema Multiforme |
5.0% |
| Neutrophil Count Decreased |
5.0% |
| Anaemia |
4.0% |
| Cerebral Infarction |
4.0% |
| Platelet Count Decreased |
4.0% |
| Decreased Appetite |
3.0% |
| Hepatic Function Abnormal |
3.0% |
| Loss Of Consciousness |
3.0% |
| Macular Oedema |
3.0% |
| Myocardial Infarction |
3.0% |
| Pancreatitis |
3.0% |
| Pneumonia |
3.0% |
| Renal Failure Acute |
3.0% |
|
